Laval, Canada

Miguel Quimpere

This inventor holds 4 USPTO granted patents. Top assignee: Biochem Pharma Inc.. Active years: 1999-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miguel Quimpere. Retrieved from https://idiyas.com/inventor/miguel-quimpere

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Miguel Quimpere: Innovator in Antiviral Compounds

Introduction

Miguel Quimpere is a notable inventor based in Laval, Canada. He has made significant contributions to the field of antiviral research, holding a total of 4 patents. His work focuses on developing nucleotide analogs that have potential therapeutic applications.

Latest Patents

Quimpere's latest patents include a process for preparing antiviral 2-phosphonate nucleotide analogs. These nucleotide analogues possess a general formula that allows for the creation of pharmaceutically acceptable derivatives. His innovative antiviral compounds are designed to combat viral infections effectively.

Career Highlights

Throughout his career, Miguel Quimpere has been associated with Biochem Pharma Inc., where he has played a crucial role in advancing antiviral research. His expertise in the field has led to the development of groundbreaking compounds that hold promise for future treatments.

Collaborations

Quimpere has collaborated with esteemed colleagues, including Nghe Nguyen-Ba and William L Brown. These partnerships have fostered a collaborative environment that enhances the research and development of antiviral therapies.

Conclusion

Miguel Quimpere's contributions to antiviral research and his innovative patents underscore his importance in the field. His work continues to pave the way for advancements in pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…